Mirum Pharmaceuticals, Inc., (NASDAQ: MIRM) a clinical-stage therapeutics company developing a novel approach for treating cholestatic liver diseases, today announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE